A prospective, multicenter, open-label, single-arm phase II study analyzing efficacy and safety of cadonilimab combined with FLOT regimen as a neoadjuvant therapy for locally advanced gastric/gastroesophageal junction adenocarcinoma
Latest Information Update: 12 Jul 2024
At a glance
- Drugs Cadonilimab (Primary) ; Docetaxel; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
Most Recent Events
- 04 Jun 2024 Results presented at the 60th Annual Meeting of the American Society of Clinical Oncology
- 11 Aug 2023 New trial record
- 01 Jul 2023 Results presented at the 25th World Congress on Gastrointestinal Cancer